Introduction of the interleukin-10 gene into mice inhibited bleomycin- induced lung injury in vivo

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 278, Issue 5 22-5, 2000, Pages

  Arai, Toru ^a   Abe, Kin'ya ^b   Matsuoka, Hiroto ^a   Yoshida, Mitsuhiro ^c   Mori, Masahide ^a   Goya, Sho ^a   Kida, Hiroshi ^a   Nishino, Kazumi ^a   Osaki, Tadashi ^a   Tachibana, Isao ^a   Kaneda, Yasufumi ^a   Hayashi, Seiji ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b Higashiosaka City General Hospital   (Japan)

^c CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Collagen; Pulmonary fibrosis; Transforming growth factor

Indexed keywords

BLEOMYCIN; COLLAGEN TYPE 1; COMPLEMENTARY DNA; CYTOKINE; HYDROXYPROLINE; INTERLEUKIN 10; MESSENGER RNA; PLATELET DERIVED GROWTH FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; FIBROBLAST; GENE EXPRESSION; HUMAN; HUMAN CELL; LUNG FIBROSIS; LUNG INJURY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 6744240499     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.2000.278.5.l914     Document Type: Article

References (48)

1. Adamson IYR, Prieditis H, and Bowden DH. Instillation of chemotactic factor to silica-injected lungs lowers interstitial particle content and reduces pulmonary fibrosis. Am J Pathol 141: 319-326, 1992.
2. Akira M, Hamada H, Sakatani M, Kobayashi C, Nishioka M, and Yamamoto S. CT findings during phase of accelerated deterioration in patients with idiopathic pulmonary fibrosis. Am J Roentgenol 168: 79-83, 1997.
3. Akira M, Sakatani M, and Ueda E. Idiopathic pulmonary fibrosis: progression of honeycombing at thin-section CT. Radiology 189: 687-691, 1993.
4. Bachem MG, Sell KM, Melchior R, Kropf J, Eller T, and Gressner AM. Tumor necrosis factor alpha (TNF alpha) and transforming growth factor beta 1 (TGF beta 1) stimulate fibronectin synthesis and the transdifferentiation of fat-storing cells in the rat liver into myofibroblasts. Virchows Arch B Cell Pathol Incl Mol Pathol 63: 123-130, 1993.
5. Bogdan C, Vodovotz Y, and Nathan C. Macrophage deactivation by interleukin 10. J Exp Med 174: 1549-1555, 1991.
6. Broekelmann TJ, Limper AH, Colby TV, and McDonald JA. Transforming growth factor beta 1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis. Proc Natl Acad Sci USA 88: 6642-6646, 1991.
7. Carmichael J, Degraff EG, Gazdar AF, Minna JD, and Mitchell JB. Evaluation of tetrazolium-based semiautomated colorimetric assay; assessment of chemosensitivity testing. Cancer Res 47: 936-942, 1987.
8. Carrington CB, Gaensler EA, Coutu RE, Fitzgerald MX, and Gupta RG. Natural history and treated course of usual and desquamative interstitial pneumonia. N Engl J Med 298: 801-809, 1978.
9. Cox G. IL-10 enhances resolution of pulmonary inflammation in vivo by promoting apoptosis of neutrophils. Am J Physiol Lung Cell Mol Physiol 271: L566-L571, 1996.
10. De Waal Malefyt R, Abrams J, Bennett B, Figdor CG, and de Vries JE Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 174: 1209-1220, 1991.
11. Denis M, Guojian L, Widmer M, and Cantin A. A mouse model of lung injury induced by microbial products: implication of tumor necrosis factor. Am J Respir Cell Mol Biol 10: 658-664, 1994.
12. Driscoll KE, Carter JM, Howard BW, Hassenbein D, Burdick M, Kunkel SL, and Strieter RM. Interleukin-10 regulates quartz-induced pulmonary inflammation in rats. Am J Physiol Lung Cell Mol Physiol 275: L887-L894, 1998.
13. Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, and O'Garra A. IL-10 inhibits cytokine production by activated macrophages. J Immunol 147: 3815-3822, 1991.
14. Fiorentino DF, Zlotnik A, Vieira P, Mosmann TR, Howard M, Moore KW, and O'Garra A. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J Immunol 146: 3444-3451, 1991.
15. Gazzinelli RT, Oswald IP, James SL, and Sher A. IL-10 inhibits parasite killing and nitrogen oxide production by IFN-gamma-activated macrophages. J Immunol 148: 1792-1796, 1992.
16. Gerard C, Bruyns C, Marchant A, Abramowicz D, Vandenabeele P, Delvaux A, Fiers W, Goldman M, and Velu T. Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J Exp Med 177: 547-550, 1993.
17. Giri SN, Hyde DM, and Hollinger MA. Effect of antibody to transforming growth factor beta on bleomycin induced accumulation of lung collagen in mice. Thorax 48: 959-966, 1993.
18. Grunfeld C and Palladino MA Jr. Tumor necrosis factor: immunologic, antitumor, metabolic, and cardiovascular activities. Adv Intern Med 35: 45-71, 1990.
19. Huaux F, Louahed J, Hudspith B, Meredith C, Delos M, Renauld JC, and Lison D. Role of interleukin-10 in the lung response to silica in mice. Am J Respir Cell Mol Biol 18: 51-59, 1998.
20. Iyonaga K, Takeya M, Saita N, Sakamoto O, Yoshimura T, Ando M, and Takahashi K. Monocyte chemoattractant protein-1 in idiopathic pulmonary fibrosis and other interstitial lung diseases. Hum Pathol 25: 455-463, 1994.
21. Izumi T, Nagai S, Kondo Y, and Tamura M. Ten-year follow up of 222 patients with idiopathic pulmonary fibrosis (IPF)-a nation-wide survey report in Japan (Abstract). Am Rev Respir Dis 145: A218, 1992.
22. Kansas GS. Selectins and their ligands: current concepts and controversies. Blood 88: 3259-3287, 1996.
23. Kato K, Kaneda Y, Sakurai M, Nakanishi M, and Okada Y. Direct injection of hepatitis B virus DNA into liver induced hepatitis in adult rats. J Biol Chem 266: 22071-22074, 1991.
24. Lossos IS, Or R, Goldstein RH, Conner MW, and Breuer R. Amelioration of bleomycin-induced pulmonary injury by cyclosporine A. Exp Lung Res 22: 337-349, 1996.
25. Lynch JP III, Standiford TJ, Rolphe MW, Kunkel SL, and Strieter RM. Neutrophilic alveolitis in idiopathic pulmonary fibrosis. The role of interleukin-8. Am Rev Respir Dis 145: 1433-1439, 1992.
26. Martinez JA, King TE Jr, Brown K, Jennings CA, Borish L, Mortenson RL, Khan TZ, Bost TW, and Riches DW. Increased expression of the interleukin-10 gene by alveolar macrophages in interstitial lung disease. Am J Physiol Lung Cell Mol Physiol 273: L676-L683, 1997.
27. Miyazaki Y, Araki K, Vesin C, Garcia I, Kapanci Y, Whitsett JA, Piguet PF, and Vassalli P. Expression of a tumor necrosis factor-alpha transgene in murine lung causes lymphocytic and fibrosing alveolitis. A mouse model of progressive pulmonary flbrosis. J Clin Invest 96: 250-259, 1995.
28. Moore KW, Rousset F, and Banchereau J. Evolving principles in immunopathology: interleukin 10 and its relationship to Epstein-Barr virus protein BCRF1. Springer Semin Immunopathol 13: 157-166, 1991.
29. Nagai S, Aung H, Takeuchi M, Kusume K, and Izumi T. IL-1 and IL-1 inhibitory activity in the culture supernatants of alveolar macrophages from patients with interstitial lung diseases. Chest 99: 674-680, 1991.
30. Nagaoka I, Trapnell BC, and Crystal RG. Upregulation of platelet-derived growth factor-A and -B gene expression in alveolar macrophage of individuals with idiopathic pulmonary fibrosis. J Clin Invest 85: 2023-2027, 1990.
31. Niwa H, Yamamura K, and Miyazaki J. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108:193-200, 1991.
32. Phan SH, Gharaee-Kermani M, McGarry B, Kunkel SL, and Wolber FW. Regulation of rat pulmonary artery endothelial cell transforming growth factor-beta production by IL-1 beta and tumor necrosis factor-alpha. J Immunol 149: 103-106, 1992.
33. Piguet PF, Collart MA, Grau GE, Kapanci Y, and Vassalli P. Tumor necrosis factor/cachectin plays a key role in bleomycin-induced pneumopathy and fibrosis. J Exp Med 170: 655-663, 1989.
34. Piguet PF and Vesin C. Treatment by human recombinant soluble TNF receptor of pulmonary fibrosis induced by bleomycin or silica in mice. Eur Respir J 7: 515-518, 1994.
35. Piguet PF, Vesin C, Grau GE, and Thompson RC. Interleukin 1 receptor antagonist (IL-1 ra) prevents or cures pulmonary fibrosis elicited in mice by bleomycin or silica. Cytokine 5: 57-61, 1993.
36. Postlethwaite AE, Holness MA, Katai H, and Raghow R. Human fibroblasts synthesize elevated levels of extracellular matrix proteins in response to interleukin 4. J Clin Invest 90: 1479-1485, 1992.
37. Reitamo S, Remitz A, Tamai K, and Uitto J. Interleukin-10 modulates type I collagen and matrix metalloproteinase gene expression in cultured human skin fibroblasts. J Clin Invest 94: 2489-2492, 1994.
38. Remick DG, Strieter RM, Eskandari MK, Nguyen DT, Genord MA, Raiford CL, and Kunkel SL. Role of tumor necrosis factor-alpha in lipopolysaccharide-induced pathologic alterations. Am J Pathol 136: 49-60, 1990.
39. Selzman CH, McIntyre RC Jr, Shames BD, Whitehill TA, Banerjee A, and Harken AH. Interleukin-10 inhibits human vascular smooth muscle proliferation. J Mol Cell Cardiol 30: 889-896, 1998.
40. Shanley TP, Schmal H, Friedl HP, Jones MH, and Ward PA, Regulatory effects of intrinsic IL-10 in IgG immune complex-induced lung injury. J Immunol 154: 3454-3460, 1995.
41. Sime PJ, Marr RA, Gauldie D, Xing Z, Hewlett BR, Graham FL, and Gauldie J. Transfer of tumor necrosis factor-alpha to rat lung induces severe pulmonary inflammation and patchy interstitial fibrogenesis with induction of transforming growth factor-betal and myofibroblasts. Am J Pathol 153: 825-832, 1998.
42. Vieira P, de Waal-Malefyt R, Dang MN, Johnson KE, Kastelein R, Fiorentino DF, deVries JE, Roncarolo MG, Mosmann TR, and Moore KW. Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: homology to Epstein-Barr virus open reading frame BCRFI. Proc Natl Acad Sci USA 88: 1172-1176, 1991.
43. Walmsley M, Katsikis PD, Abney E, Parry S, Williams RO, Maini RN, and Feldmann M. Interleukin-10 inhibition of the progression of established collagen induced arthritis. Arthritis Rheum 39: 495-603, 1996.
44. Wang P, Wu P, Anthes JC, Siegel MI, Egan RW, and Billah MM. Interleukin-10 inhibits interleukin-8 production in human neutrophils. Blood 83: 2678-2683, 1994.
45. Wang SC, Ohata M, Schrum L, Rippe RA, and Tsukamoto H. Expression of interleukin-10 by in vitro and in vivo activated hepatic stellate cells. J Biol Chem 273: 302-308, 1998.
46. Wangoo A, Laban C, Cook HT, Glenville B, and Shaw RJ. Interleukin-10- and corticosteroid-induced reduction in type I procollagen in a human ex vivo scar culture. Int J Exp Pathol 78: 33-41, 1997.
47. Woessner JF Jr. The determination of hydroxyproline in tissue and protein samples containing small proportions of this amino acid. Arch Biochem Biophys 93: 440-447, 1961.
48. Zhang Y, Lee TC, Guillemin B, Yu MC, and Rom WN. Enhanced IL-1 beta and tumor necrosis factor-alpha release and messenger RNA expression in macrophages from idiopathic pulmonary fibrosis or after asbestos exposure. J Immunol 150: 4188-4196, 1993.